Skip to comments.China probes drugmaker Sanofi for alleged bribery
Posted on 08/10/2013 8:10:25 AM PDT by Olog-hai
Chinese authorities have launched an investigation against French drugmaker Sanofi following a news report that accused the company of bribing hundreds of Chinese doctors in 2007.
An unnamed whistleblower told the Guangzhou-based, state-owned 21st Century Business Herald that the French company had paid 503 doctors a total of $274,000 to prescribe Sanofi products, disguising the payments as grants for research programs.
Chinas official Xinhua News Agency said Saturday that the Beijing municipal health bureau was teaming up with disciplinary authorities to look into the research programs and determine whether the payments were actually bribes.
(Excerpt) Read more at hosted.ap.org ...
“Chinas official Xinhua News Agency said Saturday that the Beijing municipal health bureau was teaming up with disciplinary authorities to look into the research programs and determine whether the payments were actually bribes.
Chinese officials going after ‘corrupt’ companies because they did not get their ‘piece-of-the-action’! ;-)
The Chinese are simply running interference for competing Chinese drug companies. They are primarily interested in extracting the most amount of money they can from companies such as this along with their technologies.
I thought this was the kind of thing the Chinese government supported.
Only when it benefits the State.
“Only when it benefits the State.”
Some of those party officials have feathered their nests nicely.
“Some of those party officials have feathered their nests nicely.”
Kind of like those crony capitalists in the Democrat Party
...and in a related story, China indicts themselves in a scheme to aldulterate seafood in sewage pond raised seafood.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.